TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND DINACICLIB

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP14837218.8

公开号：

EP3035964A1

申请日:

2014.08.15

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and the CDK inhibitor dincaciclib, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/